semaglutide & tirzepatide stafford Frontiers Semaglutide, tirzepatide recommended as first-line

Wambier Journal JAAD International (Journal of the American Academy of Dermatology) Year 2025 Study type Retrospective clinical study with blinded evaluation and AI-assisted assessment Sample size 7 male patients, ages 2855, Norwood-Hamilton IIIIV Full paper PubMed PMID 40225275 Full text (PMC) DOI: 10.1016/j.jdin.2025.01.012 Reviewed by: Esther Bodde Cosmetic & Medical Doctor (MD) Why This Research Matters This 2025 study is one of the first to combine three active ingredients minoxidil, dutasteride, and copper peptides delivered directly into the scalp using a medical-grade tattooing technique

Kidney Int (2022) 102(5S):S1S127

10.1016/j.bbrc.2019.08.117 Biochem

Food and Drug Administration (F.D.A.) approved a smaller dose of the drug for treating diabetes in 2017, as well as a larger dose of the drug for treating obesity in 2021, branded under the name Wegovy